Intuitive Surgical, Inc. Payments to Acquire Marketable Securities
Intuitive Surgical, Inc. (ISRG) reported Payments to Acquire Marketable Securities of $1.35 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-21.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-07-21
- Intuitive Surgical, Inc. payments to acquire marketable securities for the quarter ending 2026-06-30 was $437.80M, a 154.53% increase year-over-year.
- Intuitive Surgical, Inc. payments to acquire marketable securities for the quarter ending 2026-03-31 was $911.30M, a 75.32% increase year-over-year.
- Intuitive Surgical, Inc. payments to acquire marketable securities for the quarter ending 2025-12-31 was $425.00M, a 70.28% decline year-over-year.
- Intuitive Surgical, Inc. payments to acquire marketable securities for the quarter ending 2025-09-30 was $99.10M, a 94.84% decline year-over-year.
- Intuitive Surgical, Inc. payments to acquire marketable securities for fiscal 2025 was $1.22B, a 76.34% decline from fiscal 2024.
- Intuitive Surgical, Inc. payments to acquire marketable securities for fiscal 2024 was $5.14B, a 132.84% increase from fiscal 2023.
- Intuitive Surgical, Inc. payments to acquire marketable securities for fiscal 2023 was $2.21B, a 57.73% increase from fiscal 2022.
- Intuitive Surgical, Inc. payments to acquire marketable securities for fiscal 2022 was $1.40B, a 78.31% decline from fiscal 2021.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 9 month as first filed | Payments to Acquire Marketable Securities 12 month | Payments to Acquire Marketable Securities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $437.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-21 | $1.35B 10-Q · filed 2026-07-21 | $1.77B derived: sum of 3 quarters · filed 2026-07-21 | $1.87B derived: sum of 4 quarters · filed 2026-07-21 | ||
| 2026-03-31 | $911.30M 10-Q · filed 2026-04-22 | $1.34B derived: sum of 2 quarters · filed 2026-04-22 | $1.44B derived: sum of 3 quarters · filed 2026-04-22 | $1.61B derived: sum of 4 quarters · filed 2026-07-21 | ||
| 2025-12-31 | $425.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $524.10M derived: sum of 2 quarters · filed 2026-02-03 | $696.10M derived: sum of 3 quarters · filed 2026-07-21 | $1.22B 10-K · filed 2026-02-03 | ||
| 2025-09-30 | $99.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-22 | $271.10M derived: sum of 2 quarters · filed 2026-07-21 | $790.90M 10-Q · filed 2025-10-22 | $2.22B derived: sum of 4 quarters · filed 2026-07-21 | ||
| 2025-06-30 | $172.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-21 | $691.80M 10-Q · filed 2026-07-21 | $2.12B derived: sum of 3 quarters · filed 2026-07-21 | $4.04B derived: sum of 4 quarters · filed 2026-07-21 | ||
| 2025-03-31 | $519.80M 10-Q · filed 2026-04-22 | $1.95B derived: sum of 2 quarters · filed 2026-04-22 | $3.87B derived: sum of 3 quarters · filed 2026-04-22 | $4.75B derived: sum of 4 quarters · filed 2026-04-22 | ||
| 2024-12-31 | $1.43B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $3.35B derived: sum of 2 quarters · filed 2026-02-03 | $4.23B derived: sum of 3 quarters · filed 2026-02-03 | $5.14B 10-K · filed 2026-02-03 | ||
| 2024-09-30 | $1.92B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-22 | $2.80B derived: sum of 2 quarters · filed 2025-10-22 | $3.71B 10-Q · filed 2025-10-22 | $5.10B derived: sum of 4 quarters · filed 2026-02-03 | ||
| 2024-06-30 | $883.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-23 | $1.79B 10-Q · filed 2025-07-23 | $3.18B derived: sum of 3 quarters · filed 2026-02-03 | $3.98B derived: sum of 4 quarters · filed 2026-02-03 | ||
| 2024-03-31 | $905.90M 10-Q · filed 2025-04-23 | $2.29B derived: sum of 2 quarters · filed 2026-02-03 | $3.10B derived: sum of 3 quarters · filed 2026-02-03 | $3.11B derived: sum of 4 quarters · filed 2026-02-03 | ||
| 2023-12-31 | $1.39B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $2.19B derived: sum of 2 quarters · filed 2026-02-03 | $2.20B derived: sum of 3 quarters · filed 2026-02-03 | $2.21B 10-K · filed 2026-02-03 | ||
| 2023-09-30 | $806.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-18 | $816.70M derived: sum of 2 quarters · filed 2024-10-18 | $820.20M 10-Q · filed 2024-10-18 | $826.10M derived: sum of 4 quarters · filed 2025-01-31 | ||
| 2023-06-30 | $10.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-19 | $14.00M 10-Q · filed 2024-07-19 | $19.90M derived: sum of 3 quarters · filed 2025-01-31 | $37.30M derived: sum of 4 quarters · filed 2025-01-31 | ||
| 2023-03-31 | $3.50M 10-Q · filed 2024-04-19 | $9.40M derived: sum of 2 quarters · filed 2025-01-31 | $26.80M derived: sum of 3 quarters · filed 2025-01-31 | $215.70M derived: sum of 4 quarters · filed 2025-01-31 | ||
| 2022-12-31 | $5.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-31 | $23.30M derived: sum of 2 quarters · filed 2025-01-31 | $212.20M derived: sum of 3 quarters · filed 2025-01-31 | $1.40B 10-K · filed 2025-01-31 | ||
| 2022-09-30 | $17.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-20 | $206.30M derived: sum of 2 quarters · filed 2023-10-20 | $1.39B 10-Q · filed 2023-10-20 | $2.63B derived: sum of 4 quarters · filed 2024-01-31 | ||
| 2022-06-30 | $188.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-24 | $1.38B 10-Q · filed 2023-07-24 | $2.61B derived: sum of 3 quarters · filed 2024-01-31 | $4.32B derived: sum of 4 quarters · filed 2024-01-31 | ||
| 2022-03-31 | $1.19B 10-Q · filed 2023-04-20 | $2.43B derived: sum of 2 quarters · filed 2024-01-31 | $4.13B derived: sum of 3 quarters · filed 2024-01-31 | $5.81B derived: sum of 4 quarters · filed 2024-01-31 | ||
| 2021-12-31 | $1.24B derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-31 | $2.94B derived: sum of 2 quarters · filed 2024-01-31 | $4.62B derived: sum of 3 quarters · filed 2024-01-31 | $6.45B 10-K · filed 2024-01-31 | ||
| 2021-09-30 | $1.71B derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-21 | $3.38B derived: sum of 2 quarters · filed 2022-10-21 | $5.21B 10-Q · filed 2022-10-21 | $6.48B derived: sum of 4 quarters · filed 2023-02-10 | ||
| 2021-06-30 | $1.67B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-22 | $3.51B 10-Q · filed 2022-07-22 | $4.78B derived: sum of 3 quarters · filed 2023-02-10 | $6.37B derived: sum of 4 quarters · filed 2023-02-10 | ||
| 2021-03-31 | $1.83B 10-Q · filed 2022-04-22 | $3.10B derived: sum of 2 quarters · filed 2023-02-10 | $4.70B derived: sum of 3 quarters · filed 2023-02-10 | $5.44B derived: sum of 4 quarters · filed 2023-02-10 | ||
| 2020-12-31 | $1.27B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $2.87B derived: sum of 2 quarters · filed 2023-02-10 | $3.60B derived: sum of 3 quarters · filed 2023-02-10 | $4.29B 10-K · filed 2023-02-10 | ||
| 2020-09-30 | $1.60B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | $2.33B derived: sum of 2 quarters · filed 2021-10-20 | $3.02B 10-Q · filed 2021-10-20 | $3.83B derived: sum of 4 quarters · filed 2022-02-03 | ||
| 2020-06-30 | $736.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-21 | $1.43B 10-Q · filed 2021-07-21 | $2.23B derived: sum of 3 quarters · filed 2022-02-03 | $2.96B derived: sum of 4 quarters · filed 2022-02-03 | ||
| 2020-03-31 | $690.00M 10-Q · filed 2021-04-21 | $1.49B derived: sum of 2 quarters · filed 2022-02-03 | $2.22B derived: sum of 3 quarters · filed 2022-02-03 | $3.04B derived: sum of 4 quarters · filed 2022-02-03 | ||
| 2019-12-31 | $802.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $1.53B derived: sum of 2 quarters · filed 2022-02-03 | $2.35B derived: sum of 3 quarters · filed 2022-02-03 | $3.35B 10-K · filed 2022-02-03 | ||
| 2019-09-30 | $727.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-19 | $1.55B derived: sum of 2 quarters · filed 2020-10-19 | $2.54B 10-Q · filed 2020-10-19 | $3.43B derived: sum of 4 quarters · filed 2021-02-10 | ||
| 2019-06-30 | $823.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-23 | $1.82B 10-Q · filed 2020-07-23 | $2.70B derived: sum of 3 quarters · filed 2021-02-10 | $3.55B derived: sum of 4 quarters · filed 2021-02-10 | ||
| 2019-03-31 | $992.30M 10-Q · filed 2020-04-17 | $1.88B derived: sum of 2 quarters · filed 2021-02-10 | $2.72B derived: sum of 3 quarters · filed 2021-02-10 | $3.14B derived: sum of 4 quarters · filed 2021-02-10 | ||
| 2018-12-31 | $887.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $1.73B derived: sum of 2 quarters · filed 2021-02-10 | $2.15B derived: sum of 3 quarters · filed 2021-02-10 | $2.58B 10-K · filed 2021-02-10 | ||
| 2018-09-30 | $842.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-18 | $1.26B derived: sum of 2 quarters · filed 2019-10-18 | $1.69B 10-Q · filed 2019-10-18 | $2.57B derived: sum of 4 quarters · filed 2020-02-07 | ||
| 2018-06-30 | $417.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-22 | $851.60M 10-Q · filed 2019-07-22 | $1.72B derived: sum of 3 quarters · filed 2020-02-07 | $2.14B derived: sum of 4 quarters · filed 2020-02-07 | ||
| 2018-03-31 | $433.70M 10-Q · filed 2019-04-19 | $1.31B derived: sum of 2 quarters · filed 2020-02-07 | $1.72B derived: sum of 3 quarters · filed 2020-02-07 | $2.26B derived: sum of 4 quarters · filed 2020-02-07 | ||
| 2017-12-31 | $872.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07 | $1.29B derived: sum of 2 quarters · filed 2020-02-07 | $1.83B derived: sum of 3 quarters · filed 2020-02-07 | $2.00B 10-K · filed 2020-02-07 | ||
| 2017-09-30 | $415.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-22 | $953.90M derived: sum of 2 quarters · filed 2018-10-22 | $1.12B 10-Q · filed 2018-10-22 | $1.81B derived: sum of 4 quarters · filed 2019-02-04 | ||
| 2017-06-30 | $538.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-20 | $707.00M 10-Q · filed 2018-07-20 | $1.40B derived: sum of 3 quarters · filed 2019-02-04 | $2.22B derived: sum of 4 quarters · filed 2019-02-04 | ||
| 2017-03-31 | $168.20M 10-Q · filed 2018-04-18 | $857.10M derived: sum of 2 quarters · filed 2019-02-04 | $1.69B derived: sum of 3 quarters · filed 2019-02-04 | $2.27B derived: sum of 4 quarters · filed 2019-02-04 | ||
| 2016-12-31 | $688.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-04 | $1.52B derived: sum of 2 quarters · filed 2019-02-04 | $2.10B derived: sum of 3 quarters · filed 2019-02-04 | $2.59B 10-K · filed 2019-02-04 | ||
| 2016-09-30 | $828.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-20 | $1.41B derived: sum of 2 quarters · filed 2017-10-20 | $1.90B 10-Q · filed 2017-10-20 | $2.60B derived: sum of 4 quarters · filed 2018-02-02 | ||
| 2016-06-30 | $580.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-21 | $1.07B 10-Q · filed 2017-07-21 | $1.77B derived: sum of 3 quarters · filed 2018-02-02 | $2.30B derived: sum of 4 quarters · filed 2018-02-02 | ||
| 2016-03-31 | $487.70M 10-Q · filed 2017-04-19 | $1.19B derived: sum of 2 quarters · filed 2018-02-02 | $1.72B derived: sum of 3 quarters · filed 2018-02-02 | $2.03B derived: sum of 4 quarters · filed 2018-02-02 | ||
| 2015-12-31 | $699.20M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-02 | $1.23B derived: sum of 2 quarters · filed 2018-02-02 | $1.54B derived: sum of 3 quarters · filed 2018-02-02 | $1.83B 10-K · filed 2018-02-02 | ||
| 2015-09-30 | $529.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-19 | $845.70M derived: sum of 2 quarters · filed 2016-10-19 | $1.13B 10-Q · filed 2016-10-19 | $1.47B derived: sum of 4 quarters · filed 2017-02-06 | ||
| 2015-06-30 | $316.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-20 | $598.90M 10-Q · filed 2016-07-20 | $940.00M derived: sum of 3 quarters · filed 2017-02-06 | $1.33B derived: sum of 4 quarters · filed 2017-02-06 | ||
| 2015-03-31 | $282.50M 10-Q · filed 2016-04-19 | $623.60M derived: sum of 2 quarters · filed 2017-02-06 | $1.01B derived: sum of 3 quarters · filed 2017-02-06 | $1.19B derived: sum of 4 quarters · filed 2017-02-06 | ||
| 2014-12-31 | $341.10M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-06 | $730.00M derived: sum of 2 quarters · filed 2017-02-06 | $911.40M derived: sum of 3 quarters · filed 2017-02-06 | $1.34B 10-K · filed 2017-02-06 | ||
| 2014-09-30 | $388.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-21 | $570.30M derived: sum of 2 quarters · filed 2015-10-21 | $1.00B 10-Q · filed 2015-10-21 | $1.32B derived: sum of 4 quarters · filed 2016-02-02 | ||
| 2014-06-30 | $181.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-22 | $614.60M 10-Q · filed 2015-07-22 | $928.30M derived: sum of 3 quarters · filed 2016-02-02 | $1.11B derived: sum of 4 quarters · filed 2016-02-02 | ||
| 2014-03-31 | $433.20M 10-Q · filed 2015-04-22 | $746.90M derived: sum of 2 quarters · filed 2016-02-02 | $929.30M derived: sum of 3 quarters · filed 2016-02-02 | $1.30B derived: sum of 4 quarters · filed 2016-02-02 | ||
| 2013-12-31 | $313.70M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-02 | $496.10M derived: sum of 2 quarters · filed 2016-02-02 | $867.70M derived: sum of 3 quarters · filed 2016-02-02 | $1.44B 10-K · filed 2016-02-02 | ||
| 2013-09-30 | $182.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-23 | $554.00M derived: sum of 2 quarters · filed 2014-10-23 | $1.13B 10-Q · filed 2014-10-23 | $1.52B derived: sum of 4 quarters · filed 2015-02-06 | ||
| 2013-06-30 | $371.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | $947.60M 10-Q · filed 2014-07-24 | $1.33B derived: sum of 3 quarters · filed 2015-02-06 | $1.76B derived: sum of 4 quarters · filed 2015-02-06 | ||
| 2013-03-31 | $576.00M 10-Q · filed 2014-04-25 | $961.10M derived: sum of 2 quarters · filed 2015-02-06 | $1.39B derived: sum of 3 quarters · filed 2015-02-06 | $1.76B derived: sum of 4 quarters · filed 2015-02-06 | ||
| 2012-12-31 | $385.10M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-06 | $811.00M derived: sum of 2 quarters · filed 2015-02-06 | $1.19B derived: sum of 3 quarters · filed 2015-02-06 | $1.83B 10-K · filed 2015-02-06 | ||
| 2012-09-30 | $425.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-18 | $802.50M derived: sum of 2 quarters · filed 2013-10-18 | $1.45B 10-Q · filed 2013-10-18 | $1.80B derived: sum of 4 quarters · filed 2014-02-03 | ||
| 2012-06-30 | $376.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-22 | $1.02B 10-Q · filed 2013-07-22 | $1.38B derived: sum of 3 quarters · filed 2014-02-03 | $1.83B derived: sum of 4 quarters · filed 2014-02-03 | ||
| 2012-03-31 | $646.30M 10-Q · filed 2013-04-19 | $1.00B derived: sum of 2 quarters · filed 2014-02-03 | $1.45B derived: sum of 3 quarters · filed 2014-02-03 | $1.93B derived: sum of 4 quarters · filed 2014-02-03 | ||
| 2011-12-31 | $356.20M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-03 | $806.30M derived: sum of 2 quarters · filed 2014-02-03 | $1.29B derived: sum of 3 quarters · filed 2014-02-03 | $1.53B 10-K · filed 2014-02-03 | ||
| 2011-09-30 | $450.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-18 | $931.30M derived: sum of 2 quarters · filed 2012-10-18 | $1.18B 10-Q · filed 2012-10-18 | $1.53B derived: sum of 4 quarters · filed 2013-02-04 | ||
| 2011-06-30 | $481.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-23 | $725.90M 10-Q · filed 2012-07-23 | $1.08B derived: sum of 3 quarters · filed 2013-02-04 | $1.51B derived: sum of 4 quarters · filed 2013-02-04 | ||
| 2011-03-31 | $244.70M 10-Q · filed 2012-04-19 | $597.90M derived: sum of 2 quarters · filed 2013-02-04 | $1.03B derived: sum of 3 quarters · filed 2013-02-04 | $1.39B derived: sum of 4 quarters · filed 2013-02-04 | ||
| 2010-12-31 | $353.20M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-04 | $781.10M derived: sum of 2 quarters · filed 2013-02-04 | $1.14B derived: sum of 3 quarters · filed 2013-02-04 | $1.39B 10-K · filed 2013-02-04 | ||
| 2010-09-30 | $427.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-19 | $789.00M derived: sum of 2 quarters · filed 2011-10-19 | $1.03B 10-Q · filed 2011-10-19 | $1.27B derived: sum of 4 quarters · filed 2012-02-06 | ||
| 2010-06-30 | $361.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-20 | $604.30M 10-Q · filed 2011-07-20 | $845.60M derived: sum of 3 quarters · filed 2012-02-06 | $1.07B derived: sum of 4 quarters · filed 2012-02-06 | ||
| 2010-03-31 | $243.20M 10-Q · filed 2011-04-20 | $484.50M derived: sum of 2 quarters · filed 2012-02-06 | $704.50M derived: sum of 3 quarters · filed 2012-02-06 | $874.00M derived: sum of 4 quarters · filed 2012-02-06 | ||
| 2009-12-31 | $241.30M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-06 | $461.30M derived: sum of 2 quarters · filed 2012-02-06 | $630.80M derived: sum of 3 quarters · filed 2012-02-06 | $764.50M 10-K · filed 2012-02-06 | $764.45M 10-K · filed 2010-01-29 | |
| 2009-09-30 | $220.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-20 | $389.50M derived: sum of 2 quarters · filed 2010-10-20 | $523.20M 10-Q · filed 2010-10-20 | $523.20M 10-Q · filed 2009-10-21 | $669.46M derived: sum of 4 quarters · filed 2011-02-01 | |
| 2009-06-30 | $169.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-23 | $303.20M 10-Q · filed 2010-07-23 | $449.46M derived: sum of 3 quarters · filed 2011-02-01 | |||
| 2009-03-31 | $133.70M 10-Q · filed 2010-04-20 | $279.96M derived: sum of 2 quarters · filed 2011-02-01 | ||||
| 2008-12-31 | $146.26M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-01 | $732.70M 10-K · filed 2011-02-01 | $732.70M 10-K · filed 2010-01-29 | |||
| 2008-09-30 | $586.44M 10-Q · filed 2009-10-21 | |||||
| 2007-12-31 | $688.35M 10-K · filed 2010-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |